Jump to:

Lorillard

Coyne Beahm, Inc. Plaintiffs, V. United States Food & Drug Administration and David A. Kessler, M.D., Commissioner of Food and Drugs, Defendants. First Amended Complaint for Dec Laratory and Injunctive Relief Civil Action, File Number 2 95cv00591

Date: 07 Sep 1995
Length: 39 pages
89278409-89278447
Jump To Images
snapshot_lor 89278409-89278447

Fields

Author
Furr, J.L.
Holton, M.L. III
Shirlen, D.A.
Vaughn, K.W.
Type
PLEA, PLEADING
Area
SPEARS,ALEXANDER/OFFICE
Alias
89278409/89278447
Site
G65
Named Person
Ballin, S.
Banzhaf, J.F. III
Clinton
Durbin, R.
Edwards, C.
Georgiades, P.
Hastings, W.
Hutt, P.B.
Kennedy, D.
Kessler, D.A.
Lancaster, H.M.
Moss, F.E.
Novitch, M.
Scarlett, T.
Smoot
Surgeon General
Synar, M.
Thompson, D.E.
Young, F.
Named Organization
Batf, Bureau of Alcohol,Tobacco and Firearms
Bureau of Chemistry
Bureau of Enforcement
Bw, Brown & Williamson
Centers for Disease Control + Prevention
Comm for Legislative Affairs
Comm on Appropriations
Comm on Commerce
Comm on Energy + Commerce
Comm on Interstate + Foreign Commerce
Congress
Consumer Subcomm
Coyne Beahm
Dean Witter
Dept of Justice
Division of Adolescent + School Health
Drug Abuse Advisory Comm
FDA, Food and Drug Administration
Ftc, Federal Trade Commission
Hew, Dept of Health Education and Welfare
Hhs, Dept of Health and Human Services
House
Interagency Comm on Smoking + Health
Internal Revenue Service
Lm, Liggett & Myers
Ma Dept of Health
NC State Bar
NCI, Natl Cancer Inst
PM, Philip Morris
RJR, R.J.Reynolds
Senate
Sgc, Surgeon General's (Advisory) Comm
Subcomm on Health + the Environment
Subcomm Rural Development Agriculture Re
Usda, U.S. Dept of Agriculture
60 Minutes
Ash, Action on Smoking & Health
Date Loaded
12 Feb 1999
Document File
89278327/89278506/Briefing Book the Food and Drug
Administration and Tobacco Regulation the Tobacco
Institute 950900
Master ID
89278328/8505

Related Documents:
Litigation
Iwoh/Produced
Author (Organization)
Usdc Middle District NC Greensboro
Womble Carlyle
Characteristic
EXTR, EXTRA
UCSF Legacy ID
est20e00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: est20e00
UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF NORTH i GREENSBORO DIVISION Civil Action, File Number 2:95CV00591 ) COYNE BEAHM, INC., ) BROWN & WILLIAMSON TOBACCO ) CORPORATION, LIGGETT GROUP INC., ) LORILLARD TOBACCO COMPANY, ) PHIL.IP MORRIS INCORPORATED, and ) RJ. REYNOLDS TOBACCO COMPANY, ) ) Plaintiffs, ) ) v. ) ) UNITED STATES FOOD & DRUG ) ADMINISTRATION and DAVID A. ) KESSLER, M.D., COMMISSIONER OF ) FOOD AND DRUGS, ) ) ) Defendants. ) 1 For their Complaint, plaintiffs allege as follows: ~>> A * FILED St ` OfFltF !-,Y. IM ~~S M CpoR L c1.rt. ~ • _...a N. 0. FIRST AMEPIDED COMPIAINT FOR DECLARATORY AND INJUNC'TIVE RELIEF NATURE OF ACTION 1. This is an action against defendant United States Food and Drug Administration ("FDA" or "Agency") and defendant Dr. David A. Kessler, Commissioner of Food and Drugs, seelong review of FDA's assertion of jurisdiction over cigarettes. FDA's action is an unprecedented and unlawful effort to extend its regulatory reach far beyond its statutory mandate and to usurp the legislative authority of Congress. FDA's action is contrary to Congress's clear intent to withhold from FDA jurisdiction over cigarettes; is
Page 2: est20e00
irreconcilable with, and precluded by, the Federal Cigarette Labeling and Advertising Act ("FCLAA"), 15 U.S.C. $ 1331; violates FDA's enabling legislation, the Federal Food, Drug, and Cosmetic Act (the "FFDCA" or the "Act"), 21 U.S.C. ff 301 et seq., and the Administrative Procedure Act ("APA"), 5 U.S.C. f§ 701 gt L M violates Articles I and II of the United States Constitution; and violates the First, Fourth, Fi1`th, Eighth, Ninth, and Tenth Amendments of the United States Constitution. 2. Plaintiffs seek a declaration that Congress has not granted FDA jurisdiction over cigarettes and that the President's direction to FDA to assert jurisdiction and FDA's consequent assertion of jurisdiction are tra vires and contrary to law. Plaintiffs also seek an injunction requiring FDA to withdraw its assertion of jurisdicti on over cigarettes and prohibiting FDA from asserting jurisdiction over, or initiating any rulemaking or enforcement proceedings based on any illegal assertion of jurisdiction over, the manufacture, labeling, or marketing of cigarettes. 3. Many authorities, including former FDA Commissioners, have stated that an assertion of jurisdiction over cigarettes as a "drug" or "drug delivery device," if allowed to stand, would empower FDA to control all aspects of cigarette ma.nufacturing, labeling and marketing. Yet Congress has never granted FDA any jurisdiction over cigarettes. To the contrary, Congress has repeatedly rejected proposed legislation that would have given FDA such authority. Rather, Congress has made its own determinatiora of how a comprehensive program for federal regulation of cigarettes should be structured - a program in which FDA has absolutely no role. FDA's unilateral assertion of jurisdiction irreconcilably conflicts with that regulatory regime on all issues related to smoking. 2
Page 3: est20e00
4. FDA's assertion of jurisdiction over cigarettes has had, and will continue to have, a substantial adverse impact on plaintiffs' business activities in this district and throughout the United States. Indeed, even FDA has acknowledged that its assertion of jurisdiction over cigarettes "could have dramatic effects on our saciety," including the creation of a black market for cigarettes. IM PARTIE.S 5. Plaintiff Coyne Beahm, Inc. ("Coyne Beahm") is a North Carolina corporation with its principal place of business in Colfax, North Carolina. A substantial portion of Coyne Beahm's revenue is derived from the marketing, advertising and promotion of cigarettes and other tobacco products. 6. Plaintiff Brown & Williamson Tobacco Corporation ("Brown & Williamson") is a Delaware corporation with major facilities in Reidsville and Winston-Salem, North Carolina. Brown & Williamson purchases substantial quantities of tobacco in this district; manufactures tobacco products at its facilities in Reidsville and Winston-Salem, within the jurisdiction of this Court; and sells and distributes finished cigarettes in this district. 7. Plaintiff Iiggett Group Inc. ("Liggett") is a Delaware corporation with a major facility in Durham, North Carolina. liggett purchases sub:,tantial quantities of tobacco in this district; manufactures cigarettes at its facility in Durham, within the jurisdiction of this Court; and sells and distributes finished cigarettes in this district. 8. Plaintiff Lorillard Tobacco Company ("Lorillard") is a Delaware corporation with a major facility in Greensboro, North Carolina. Lorillard pu rchases substantial 3
Page 4: est20e00
quantities of tobacco in this district; manufactures cigarettes at its facility in Greensboro, within the jurisdiction of this Court; and sells and distributes finished cigarettes in this district. 9. Plaintiff Philip Morris Incorporated ("Philip Morri;") is a Virginia corporation with a major manufacturing facility in Concord, North Carolina. Philip Morris purchases substantial quantities of tobacco in this district; manufactures cigarettes at its facility in Concord, within the jurisdiction of this Court; and sells and distributes finished cigarettes in this district. 10. Plaintiff R.J. Reynolds Tobacco Company ("Reynolds") is a New Jersey corporation with a major facility in Winston-Salem, North Carolina. Reynolds purchases substantial quantities of tobacco in this district; manufactures cigarettes at its facility in Winston-Salem, within the jurisdiction of this Court; and sells and distributes finished cigarettes in this district. 11. Defendant FDA is an executive agency within the Department of Health and Human Services, established to carry out acts of Congress concerning foods, drugs, devices and cosmetics. 21 U.S.C. § 393; 5 C.F.R. § 5.10(a)(7). FDA is subject to, and derives its authority to regulate "drugs" or "medical devices" from, the FFDC.i . 12. Defendant Dr. David A. Kessler is the Commissioner of Food and Drugs, the head of FDA. JURISDICTION AND VENUE 13. This Court has jurisdiction over this action pursuant to 28 U.S.C. § 1331. Declaratory relief is authorized by 28 U.S.C. §§ :201-2202 and Fed. R. Civ. P. 57. Judicial 4
Page 5: est20e00
review is also authorized under the Administrative Procedure Act (the "APA"), 5 U.S.C. §§ 701 et seg. 14. Venue in this district is proper pursuant to 28 U.S.C. § 1391(e). BACKGROUND 15. On August 10, 1995, Commissioner Kessler issuai a Notice of Proposed Rulemaking indicating that FDA has jurisdiction over cigarettes. Commissioner Kessler took this action notwithstanding (a) that Congress has in fact withheld any such jurisdiction from FDA and (b) that Commissioner Kessler, and his predecessors, had previously recognized that FDA has no such authority over cigarettes sold without any ther-apeutic claims. Plaintiff tobacco companies do not make any claims of therapeutic purpose for their cigarettes. Their cigarettes are promoted solely for smoking pleasure. 16. In the name of preventing youth smoking, FDA's rule, among other things: • Imposes a $150 million tax on the manufacturers. • Establishes a national minimum age for smoking. • Holds cigarette manufacturers liable for any sale of cigarettes to minors by retailers who are in no way subjea to the authority or control of the manufacturers. • Bans certain forms of advertising. • Bans the sale of cigarettes in vending machines. • Regulates the sale of cigarettes in grocery stores, pharmacies, gas stations, convenience stores, and other ;?laces. • Imposes federal (FDA) control over labelin,g and advertising as is imposed over prescription drugs. • Requires a new warning in cigarette advertising. op ~ N ~ m 5 W
Page 6: est20e00
• Divests property interests in registered trademarks by placing federal limits on brand advertising and the use of cigarette brand names. • Precludes brand name sponsorship of artistic, cultural and sporting events. • Prevents distribution of cigarettes in anything other than federally approved package sizes. • Generally subjects cigarettes and cigarette manufacturers to FDA enforcement mechanisms for medical devices, including detention, judicial seizure, FDA-mandated re:call and FDA- mandated cessation of marketing, safety notification to users, civil money penalties, judicial injunction and criminal prosecution. Congress Has Withheld From FDA Any Authority to Regulate ~,igarettes 17. For more than eight decades, Congress has made clear that cigarettes are not subject to FDA jurisdiction. The issue of smoking and health has 'been a matter of substantial scientific, public and congressional interest for many years. Consistent with this attention, the issue of whether FDA can assert jurisdiction over cigarettes has been raised in Congress many times. Each time, however; Congress has determined that FDA should. have no jurisdiction over cigarettes. - 18. The Pure Food and Drugs Act of 1906, P.L No. 59-384, 34 Stat. 763 (1906), gave FDA's predecessor, the Bureau of Chemistry in the Department of Agriculture, no authority over tobacco products. 6
Page 7: est20e00
19. As the Bureau of Chemistry stated in 1914, tobaixo products, which, like plaintiffs' cigarettes, were not labeled for any "medicinal purpose," were beyond the scope of the Food and Drugs Act of 1906: "[T]obacco and its preparations, when labeled in such a manner as to indicate their use for the cure, mitigation, or prevention of disease, are drugs within the meaning of the act, and, as such, are subject to the provisions thereof. "On the other hand, tobacco and its prepararions which are not so labeled and are used for smoking or che-win¢ or as snuff and not for medicinal purnoses are not subject to the provisions of the act." Service and Re lu atorYAnnouncements. No. 13 (Feb. 1914; issued Apr. 2, 1914) (emphasis added). 20. This fundamental position did not change following the enactment of the FFDCA in 1938. Indeed, over a twelve year period from 1940 to 1952, FDA and its predecessor agencies charged with interpretation of the FFDCA consistently stated in correspondence to Congress that cigarettes are not "drugs" or "de:vices" under the Act absent a claim by the manufacturer of some therapeutic benefit. See Biief for Appellee (FDA), ASH v. Harris, 655 F.2d 236 (D.C. Cir. 1980) (No. 79-1397). 21. Just as clearly, every attempt to extend the scope of the FFDCA to cigarettes has been rejected. In 1929, anti-tobacco forces introduced legishition to bring tobacco products within the jurisdiction of the federal agencies that enforce the nation's drug laws. S. 1468, 71st Cong., 1st Sess. (1929). See also 71 Cong. Rec. 2589 (June 10, 1929) (comments and bill introduced by Sen. Smoot). That bill did not pass. 22. In 1956, another bill was introduced to amend the FFDCA to grant FDA m to authority over cigarettes. H.R. 11280, 84th Cong., 2d Sess. (1956). The bill did not pass. tv ~1 OD ~ 7 N tn
Page 8: est20e00
23. In 1963, bills to amend the FFDCA to grant FDA jurisdiction over cigarettes were introduced in both Houses of Congress. S. 1682, 88th Conj;., 1st Sess. (1963); H.R. 5973, 88th Cong., 1st Sess (1963). The purpose of this legiudation was to place "all smoking products under the authority of the Food and Drug Ad=ninistration." 109 Cone. Ze . 10316, 10317 (June 6, 1963) (statement of Sen. Moss). According to their sponsor, the bills were introduced because it was clear that "smoking products do not come under the protection of the FDA." Id. at 10318. Again, however, the bills did not pass. 24. In 1964, a report was published by the Advisory Committee to the Surgeon General on Smoking and Health concerning the possible risks of smoking. Congress reserved to itself the responsibility to respond to that report. As the Hou:,e Committee on Interstate and Foreign Commerce observed: 'The determination of approp.nate remedial action in this area, as7ecommended by the Surgeon General's Advisory Committee, is a responsibility which should be exercised by Congress after considering all facets of the problem." H.R. Rep. No. 449, 89th Cong., 1st Sess. 1, reprinted in 1965 U.S.C:.C:.A.N. 2350, 2351-52. 25. Once again, one of the proposed responses to the: Surgeon General's report which was considered by Congress was to mctend FDA jurisdiction to include cigarettes. H.R. 2448, 89th Cong., 1st Sess. (1965). Both the proponents and opponents of that proposal recognized that, absent such new legislation, FDA has no authority over cigarettes. Again, however, the proposed bills to give FDA jurisdiction over tobacco products did not pass. 26. Instead, as described in greater detail below, Congress enacted the FCLAA. Congress made clear that the FCLAA - not the FFDCA - established "a comprehensive ~ N ~ m 8 1, ~
Page 9: est20e00
Federal program to deal with cigarette labeling and advertising Mrith respect to in relationship between smoking and health." 15 U.S.C. § 1331 (emphasis added). 27. Congress did not provide any role for. FDA in its "comprehensive Federal program." To the contrary, Congress i ited any entity (including FDA) from requiring any labels or warnings with respect to cigarettes other than those: which Congress specifically set forth in the FCLAA. 15 U.S.C. § 1334. 28. Congressional consideration - and rejection - oi' proposals to have FDA regulate cigarettes has continued since the enactment of the FCLAA: (a) In 1977, 1978, and 1979, five different bills were introduced in Congress to grant FDA jurisdiction over cigarettes. None of them passed. (b) In 1984, the House Committee on Energy and Commerce observed - that "Federal laws that protect the public from hazardous food, drugs and consumer products do not apply to cigarettes ...." H. Rep. No. 98-805, 98th Cong., 2d Sess. 12, revrinted in 1984 U.S.C.C.A.N. 3718, 3725. And no legislation to change that situation was enacted. (c) In 1987, H.R. 3294,was introduced to exp 3nd FDA jurisdiction by creating a new regulatory category for tobacco products. The bill did not pass. (d) In 1989, H.R. 1494 and S. 769 were introduced to expand FDA jurisdiction by creating a new regulatory category for tobacco products. The bills did not pass. M CD N ~ 9 N ~
Page 10: est20e00
(e) Even Rep. Richard Durbin, a staunch critic of tobacco products, conceded in 1989 that FDA's jurisdiction does not extend to tobacco: "It would seem that if you looked at the spectrum of products sold in America, [tobacco] stands out as an extraordinary exception to your mandate under the FDA. ... ". .. There have been tests over the years in court as to whether or not tobacco is included in the Food, Drug and Cosmetics Act, and the courts have generally conc;luded it is not. In fact, I think they have concluded unanimously that it is not an ingested food, nor is it a drug taken for an illness !)r to change some type of bodv 'structure." Hearings before the Subcomm. on Rural Developen AQriculture, and Related Agencies, of the House C~omm. on Appropriations. 100th Cong., 2d Sess., part 8, at 408 (1989) (emphasis added). 29. In the 1990s, Congress continued to confirm that FDA has no role in regulating cigarettes: (a) In 1992, H.R. 4350 and S. 2298 were introduced to expand FDA jurisdiction by creating a new regulatory category for tob acco products. In connection with that legislation, Rep. Michael Synar, a major opponent of cigarettes, conceded that, "While the FDA has jurisdiction to prote:t consumers from unsafe foods, drugs, cosmetics and medical devices, it is powerless to do anything about one of the deadliest consumer products - tobacco." 138 Cong. Rec. E483 (1992) (emphasis added). Neither bill passed. (b) In 1993, H.R. 2147 and S. 672 were introduced to expand FDA jurisdiction by creating a new regulatory categoi, for tobacco products. Again, the bills did not pass. 10

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: